Tioga says IBS drug shows success in patients with pain, diarrhea

05/27/2008 | MedPage Today (free registration)

Tioga Pharmaceuticals says its investigational oral kappa opioid agonist, asimadoline, gave modest relief to patients with irritable bowel syndrome who had moderate to severe pain and diarrhea. Trials show the drug did not benefit people with constipation-predominant IBS or patients with only mild pain.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC